Happy Match Day 2024! Good luck to all! #RxMatchDay

It's #ThrowbackThursday as we review the POPular-AGE trial. This showed a significant reduction in bleeding and non-inferiority for net benefit with clopidogrel compared to ticagrelor for patients >70 with NSTEMI. Graphic by Ellie Kang at Texas A&M Pharmacy pubmed.ncbi.nlm.nih.gov/32334703/

DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction - Implications for clinicians 🆓doi.org/10.1093/ndt/gf… ➡️These drugs are safe but not beneficial in such patients

🫘Etiology of AKI in Cirrhosis journals.lww.com/cjasn/fulltext… ASN Publications

Super excited for my fellow LAPPE students and the experiences they’ll have at their programs! I know for a fact these programs are going to have excellent set of residents ☺️

Congratulations Christina Kang! The ACCPpostgrads community looks forward to supporting your pursuit of PGY1 pharmacy residency training at The University of Texas Medical Branch. #CongratsPostGrad #RxMatch2025 Ellie UTMB Health

wake up babe urine for a treat w these new guidelines